Home/Oleander Medical Technologies/Harry J. Gould, III, M.D., Ph.D.

HJ

Harry J. Gould, III, M.D., Ph.D.

Chief Medical Officer

Oleander Medical Technologies

Therapeutic Areas

Oleander Medical Technologies Pipeline

Drug	Indication	Phase
Targeted Osmotic Lysis (TOL)	Advanced/Invasive Cancers	Pre-clinical

Leadership Team at Oleander Medical Technologies

Paige R. Miller, J.D.

President & CEO

Dennis Paul, Ph.D.

Chief Science Officer

View full Oleander Medical Technologies profile